METTL3 silencing reduced the expression of the glioma reprogramming factors POU3F2, SOX2, SALL2 and OLIG2, and suppressed GSC proliferation in neurosphere assays derived from human glioma cell lines. This evidence concerns the gene SALL2 and central nervous system cancer.